Jasmin Kunz, MS, CF-SLP in La Vista, NE - Speech-Language Pathologist

Jasmin Kunz, MS, CF-SLP is a Speech-language Pathologist based in La Vista, Nebraska. Jasmin Kunz is licensed to practice in * (Not Available) (license number ) and her current practice location is 7821 Terry Dr, La Vista, Nebraska. She can be reached at her office (for appointments etc.) via phone at (402) 898-0463.

NPI number for Jasmin Kunz is 1962921189 and her current mailing address is 715 N 82nd Plz Apt 3, Omaha, Nebraska. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1962921189.

Contact Information

	Jasmin Kunz, MS, CF-SLP
	7821 Terry Dr, La Vista, NE 68128-3943
	(402) 898-0463
	Not Available

Healthcare Provider's Profile

Full Name	Jasmin Kunz
Gender	Female
Speciality	Speech-language Pathologist
Location	7821 Terry Dr, La Vista, Nebraska
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1962921189
Provider Enumeration Date: 09/19/2017
Last Update Date: 09/19/2017

Medical Identifiers

Medical identifiers for Jasmin Kunz such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1962921189	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jasmin Kunz is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jasmin Kunz, MS, CF-SLP 715 N 82nd Plz Apt 3, Omaha, NE 68114-3590 Ph: () -	Jasmin Kunz, MS, CF-SLP 7821 Terry Dr, La Vista, NE 68128-3943 Ph: (402) 898-0463

News Archive

Researchers use optical mapping system to observe the effect of hydroxychloroquine

The malaria drug hydroxychloroquine, which has been promoted as a potential treatment for Covid-19, is known to have potentially serious effects on heart rhythms.

FDA approves risk management program on ESA's for treating anemia due to chemotherapy

The U.S. Food and Drug Administration today approved a risk management program to inform healthcare providers and their patients about the risks of a class of drugs called Erythropoiesis-Stimulating Agents (ESAs). For patients with cancer, the program is also designed to help ensure the appropriate administration of these drugs, which they receive to treat anemia that can occur as a result of chemotherapy.

Ret enzyme may be a novel therapeutic target in selected groups of breast cancer patients

Scientists at the MedUni Vienna, in collaboration with a working group led by Nancy Hynes at the University of Basel, have discovered a new approach in the treatment of breast cancer: an international team involving the Clinical Institute of Pathology at the MedUni Vienna has been able to demonstrate the activation of a receptor, the Ret protein (Rearranged during transfection), on the surface of breast cancer cells. Increased levels of this protein are associated with a lower likelihood of survival for breast cancer patients.

Rural/Metro Corporation chosen to provide emergency ambulance services in Ohio

Rural/Metro Corporation, a leading national provider of ambulance and private fire protection services, has been awarded a new long-term contract to continue providing exclusive emergency ambulance services to the City of Youngstown, Ohio.

Simple placebo pill can track footprints of prior antidepressant use

Individuals with major depressive disorder (MDD) often undergo multiple courses of antidepressant treatment during their lives. This is because the disorder can recur despite treatment and because finding the right medication for a specific individual can take time.

Speech-Language Pathologist in La Vista, NE

Ms. Deanna Lynn Twait, MSCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6960 S 110th St, La Vista, NE 68128 Phone: 402-597-4990
Cassie Marie Gay, MS, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 9735 Florence St, La Vista, NE 68128 Phone: 088-293-2329
Michelle Reilly Lanoue, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7900 Edgewood Blvd, La Vista, NE 68128 Phone: 402-898-0436
Mrs. Kendra Kay Speece, .M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8541 S 99th Cir, La Vista, NE 68128 Phone: 402-658-8627
Erica Smith, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7609 S 89th St, La Vista, NE 68128 Phone: 402-898-0433
Madeline Clauson, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7600 S 72nd St, La Vista, NE 68128 Phone: 402-517-8012
Andrea Berry, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8009 S 67th Street Cir, La Vista, NE 68128 Phone: 816-863-8868

Jasmin Kunz, MS, CF-SLP - Speech-Language Pathologist in La Vista, NE